Literature DB >> 12898523

Phosphorylation regulates the interaction and complex formation between wt p53 protein and PARP-1.

Józefa Wesierska-Gadek1, Jacek Wojciechowski, Gerald Schmid.   

Abstract

We recently characterized the interaction between poly(ADP-ribose) polymerase-1 (PARP-1) and the product of the tumor suppressor gene p53. We investigated which domains of human PARP-1 and of human wild-type (wt) p53 were involved in this protein-protein interaction. We generated baculoviral constructs encoding full length or distinct functional domains of both proteins. Full length PARP-1 was simultaneously coexpressed in insect cells with full length wt p53 protein or its distinct truncated fragments and vice versa. Reciprocal immunoprecipitation of Sf9 cell lysates revealed that the central and carboxy-terminal fragments of p53 were sufficient to confer binding to PARP-1, whereas the amino-terminal part harboring the transactivation functional domain was dispensable. On the other hand, the amino-terminal and central fragments of PARP-1 were necessary for complex formation with p53 protein. As the most important features of p53 protein are regulated by phosphorylation, we addressed the question of whether its phosphorylation is essential for binding between the two proteins. Baculovirally expressed wt p53 was post-translationally modified. At least six distinct p53 isomeres were resolved by immunoblotting following two-dimensional separation of baculovirally expressed wt p53 protein. Using specific phospho-serine antibodies, we identified phosphorylation of baculovirally expressed p53 protein at five distinct sites. To define the role of p53 phosphorylation, pull-down assays using untreated and dephosphorylated p53 protein were performed. Dephosphorylated p53 failed to bind PARP-1 indicating that complex formation between both proteins is regulated by phosphorylation of p53. The marked phosphorylation of p53 at Ser392 observed in unstressed cells suggests that the phosphorylated carboxy-terminal part of p53 undergoes complex formation with PARP-1 resulting in masking of the NES and thereby preventing its export. The functional significance of the interaction between both proteins was investigated at two different conditions: inactivation of PARP-1 and overexpression of PARP-1. Our results unequivocally show that the presence of PARP-1 regulates the basal expression of wt p53 in unstressed cells. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12898523     DOI: 10.1002/jcb.10569

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  8 in total

1.  Inhibition of Aurora-B kinase activity by poly(ADP-ribosyl)ation in response to DNA damage.

Authors:  Lucia Monaco; Ullas Kolthur-Seetharam; Romain Loury; Josiane Ménissier-de Murcia; Gilbert de Murcia; Paolo Sassone-Corsi
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-22       Impact factor: 11.205

Review 2.  Poly(ADP-ribose) polymerase: the nuclear target in signal transduction and its role in brain ischemia-reperfusion injury.

Authors:  Robert Piotr Strosznajder; Henryk Jesko; Agata Zambrzycka
Journal:  Mol Neurobiol       Date:  2005       Impact factor: 5.590

Review 3.  Poly (ADP-ribose) polymerase: An Overview of Mechanistic Approaches and Therapeutic Opportunities in the Management of Stroke.

Authors:  Palak Tiwari; Heena Khan; Thakur Gurjeet Singh; Amarjot Kaur Grewal
Journal:  Neurochem Res       Date:  2022-04-18       Impact factor: 3.996

4.  Inhibition of AKT induces p53/SIRT6/PARP1-dependent parthanatos to suppress tumor growth.

Authors:  Yizheng Zhang; Chuchu Zhang; Jiehan Li; Meimei Jiang; Shuning Guo; Ge Yang; Lingling Zhang; Feng Wang; Shiqi Yi; Jiangang Wang; Yang Fu; Yingjie Zhang
Journal:  Cell Commun Signal       Date:  2022-06-17       Impact factor: 7.525

5.  Oncogenes do not Fully Override Cell-intrinsic Traits: Pronounced Impact of the Cellular Programme.

Authors:  Józefa Węsierska-Gądek; Eva Walzi; Iva Dolečkova; Gerald Schmid
Journal:  Cancer Microenviron       Date:  2009-09-04

Review 6.  Poly(ADP-ribosyl)ation in mammalian ageing.

Authors:  Sascha Beneke; Alexander Bürkle
Journal:  Nucleic Acids Res       Date:  2007-10-02       Impact factor: 16.971

7.  Mortaparib, a novel dual inhibitor of mortalin and PARP1, is a potential drug candidate for ovarian and cervical cancers.

Authors:  Jayarani F Putri; Priyanshu Bhargava; Jaspreet Kaur Dhanjal; Tomoko Yaguchi; Durai Sundar; Sunil C Kaul; Renu Wadhwa
Journal:  J Exp Clin Cancer Res       Date:  2019-12-19

8.  PARP inhibition potentiates the cytotoxic activity of C-1305, a selective inhibitor of topoisomerase II, in human BRCA1-positive breast cancer cells.

Authors:  Józefa Węsierska-Gądek; Nora Zulehner; Franziska Ferk; Andrzej Składanowski; Oxana Komina; Margarita Maurer
Journal:  Biochem Pharmacol       Date:  2012-08-14       Impact factor: 5.858

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.